Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing

Lung cancer is the most common cause of cancer-related deaths. Lung cancers can be classified as small-cell (SCLC) or non-small cell (NSCLC). About 84% of all lung cancers are NSCLC and about 16% are SCLC. For the past few years, there have been a lot of new advances in the management of NSCLC in te...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajasegaran, Thiviyadarshini, How, Chee Wun, Saud, Anoosha, Ali, Azhar, Lim, Jonathan Chee Woei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051080/
https://www.ncbi.nlm.nih.gov/pubmed/36986550
http://dx.doi.org/10.3390/ph16030451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051080/
https://www.ncbi.nlm.nih.gov/pubmed/36986550
http://dx.doi.org/10.3390/ph16030451

Ejemplares similares